Home » Topics » Drugs » Immuno-oncology

Immuno-oncology
RSS

AltaRex initiates U.S. phase IIb trial with Ovarex

May 28, 1997

Bexxar as first-line therapy for non-Hodgkin's lymphoma

May 26, 1997

Preliminary phase II and phase I/II results for Allovectin-7

May 22, 1997

Preliminary results indicate potential for AML treatment

May 21, 1997

Techniclone reports promising results from brain cancer treatment study

May 21, 1997

Somatix reports promising results from melanoma vaccine trials

May 21, 1997

Ribi theraccine available for licensing outside Canada

May 19, 1997

NIH announces prospective grant of exclusive license for IL-13 receptor-specific chimeric antibodies

May 16, 1997

Phase I/II results for Glaxo's tucaresol in metastatic melanoma

May 15, 1997

Ilex and LeukoSite form joint venture for development of Campath-1H

May 14, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...